News & Updates

Show Multimedia Only
What fuels flu, pneumococcal vaccine hesitancy in SG?
What fuels flu, pneumococcal vaccine hesitancy in SG?
23 Sep 2024 byJairia Dela Cruz

In Singapore, influenza and pneumococcal vaccination coverage remains stubbornly low. Results of two separate analysis of a cross-sectional survey shed light on this concerning trend, highlighting the roles of vaccine knowledge and attitude, healthcare professionals, and social support in influencing vaccination decisions.

What fuels flu, pneumococcal vaccine hesitancy in SG?
23 Sep 2024
Depemokimab a safe remedy for severe asthma exacerbations
Depemokimab a safe remedy for severe asthma exacerbations
20 Sep 2024
Benralizumab trumps steroids in treatment of asthma, COPD eosinophilic exacerbations
Benralizumab trumps steroids in treatment of asthma, COPD eosinophilic exacerbations
20 Sep 2024 byStephen Padilla

The time of steroids as the treatment of choice for asthma and chronic obstructive pulmonary disease (COPD) exacerbations appears to be nearing its end with the arrival of a new monoclonal antibody therapy, according to the results of the ABRA study.

Benralizumab trumps steroids in treatment of asthma, COPD eosinophilic exacerbations
20 Sep 2024
COVID-19 variants carry no increased autoimmune sequelae risk
COVID-19 variants carry no increased autoimmune sequelae risk
16 Sep 2024 byJairia Dela Cruz

COVID-19 variants delta and omicron BA.1 or BA.2 do not pose a substantial threat of long-term autoimmune complications, except for a modest elevation in inflammatory bowel disease and bullous skin disorders among hospitalized patients during the omicron predominance in Singapore, as shown in a study.

COVID-19 variants carry no increased autoimmune sequelae risk
16 Sep 2024